You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 諾誠健華-B(9969.HK)續升6% 6日漲幅近20% 股價有望衝擊歷史高位
格隆匯 04-20 11:31
格隆匯4月20日丨諾誠健華-B(9969.HK)拉昇漲5.95%,6日累計漲幅近20%。現報22.25港元有望衝擊歷史高位,總市值335億港元。諾誠健華公佈,旗下新型多靶點受體酪氨酸激酶抑制劑ICP-033,新藥研究申請已獲國家藥品監督管理局受理。諾誠健華聯合創始人、董事長兼CEO崔霽松表示,ICP-033為公司第六個進入臨牀階段的創新藥,將進一步豐富實體瘤領域的產品管線,為全球癌症患者提供更多治療選擇。另外,高盛此前諾誠健華予以“買入”評級,以反映2月份配股所得資金,以及公司將於今明兩年加大研發投入。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account